Skip to main content
. 2025 Feb 28;2025(1):e202504. doi: 10.21542/gcsp.2025.4

Table 2. Procedural and clinical characteristics of patients stratified by quintiles.

Values are presented as number (percentage).

Variable Quintile 1 (Q1) Quintile 2 (Q2) Quintile 3 (Q3) Quintile 4 (Q4) Quintile 5 (Q5) P-value (trend)
Total number of patients 78,670 (100%) 87,405 (100%) 87,405 (100%) 86,069 (100%) 97,475 (100%) <0.0001
STEMI 12,589 (16.0%) 14,841 (17.0%) 15,350 (17.6%) 16,437 (19.1%) 19,803 (20.3%) <0.0001
Stable Angina 24,375 (31.0%) 27,684 (31.7%) 28,500 (32.6%) 29,124 (33.8%) 31,612 (32.4%) <0.0001
NSTEMI 30,177 (38.4%) 30,937 (35.4%) 31,054 (35.5%) 32,714 (38.0%) 34,036 (34.9%) 0.08
Q-wave on presenting ECG 5,100 (6.5%) 6,875 (7.9%) 8,000 (9.2%) 8,035 (9.3%) 8,988 (9.2%) 0.12
Arterial access
Femoral 2,555 (3.2%) 2,640 (3.0%) 2,422 (2.8%) 2,576 (3.0%) 2,623 (2.7%) 0.07
Radial 6,706 (8.5%) 8,498 (9.7%) 9,060 (10.4%) 9,476 (11.0%) 10,348 (10.6%) <0.0001
Pre-procedure TIMI flow
0 3,119 (4.0%) 3,660 (4.2%) 4,100 (4.7%) 4,130 (4.8%) 4,860 (5.0%) <0.0001
1 752 (1.0%) 1,044 (1.2%) 1,331 (1.5%) 1,410 (1.6%) 1,625 (1.7%) <0.0001
2 1,395 (1.8%) 1,842 (2.1%) 2,022 (2.3%) 2,290 (2.7%) 2,775 (2.9%) <0.0001
3 3,059 (3.9%) 3,558 (4.1%) 3,714 (4.2%) 3,950 (4.6%) 4,330 (4.4%) <0.0001
Cardiogenic shock pre-procedure 262 (0.3%) 402 (0.5%) 496 (0.6%) 537 (0.6%) 838 (0.9%) <0.0001
Vessel attempted
LM 142 (0.18%) 202 (0.23%) 230 (0.26%) 237 (0.28%) 241 (0.25%) 0.11
LAD 3,479 (4.4%) 4,190 (4.8%) 4,640 (5.3%) 4,970 (5.8%) 5,580 (5.7%) 0.48
RCA 2,416 (3.1%) 3,400 (3.9%) 3,460 (4.0%) 3,780 (4.4%) 3,970 (4.1%) 0.23
LCx 1,925 (2.5%) 2,850 (3.3%) 2,915 (3.3%) 3,065 (3.6%) 3,760 (3.9%) 0.06
Grafts 405 (0.5%) 655 (0.8%) 748 (0.9%) 737 (0.9%) 763 (0.8%) 0.14
MVD 3,519 (4.5%) 4,275 (4.9%) 4,615 (5.3%) 4,935 (5.7%) 5,900 (6.0%) 0.03
Anti-thrombotic agent used
Heparin only 25,051 (31.8%) 29,784 (34.1%) 32,495 (37.2%) 34,940 (40.6%) 38,530 (39.5%) <0.0001
Heparin + GPIIb/IIIa 8,641 (11.0%) 11,678 (13.4%) 12,578 (14.4%) 13,365 (15.5%) 14,745 (15.1%) <0.0001
Bivalirudin 3,107 (3.9%) 4,285 (4.9%) 4,448 (5.1%) 4,570 (5.3%) 5,485 (5.6%) 0.14
Warfarin 1,200 (1.5%) 1,780 (2.0%) 2,062 (2.4%) 2,222 (2.6%) 2,562 (2.6%) 0.12
Any circulatory support
IABP used 2,031 (2.6%) 2,878 (3.3%) 3,056 (3.5%) 3,200 (3.7%) 3,535 (3.6%) <0.0001
Ventilated 1,336 (1.7%) 1,901 (2.2%) 2,086 (2.4%) 2,250 (2.6%) 2,573 (2.6%) 0.018
Post-procedure TIMI flow
0 892 (1.1%) 1,085 (1.2%) 1,171 (1.3%) 1,251 (1.5%) 1,472 (1.5%) 0.04
1 216 (0.3%) 293 (0.3%) 339 (0.4%) 393 (0.5%) 468 (0.5%) 0.03
2 1,020 (1.3%) 1,233 (1.4%) 1,317 (1.5%) 1,391 (1.6%) 1,536 (1.6%) <0.0001
3 6,342 (8.1%) 7,555 (8.6%) 8,073 (9.2%) 8,475 (9.8%) 26,123 (26.8%) <0.0001

Notes.

ACS
acute coronary syndrome
ECG
electrocardiogram
IABP
intra-aortic balloon pump
LAD
left anterior descending artery
LCx
left circumflex artery
LM
left main artery
MVD
multivessel disease
NSTEMI
non-ST-segment elevation myocardial infarction
PCI
percutaneous coronary intervention
RCA
right coronary artery
STEMI
STsegment-elevation myocardial infarction
TIMI
Thrombolysis in Myocardial Infarction
GPIIb/IIIa
glycoprotein IIb/IIIa inhibitor